Revolution Medicines (NASDAQ: RVMD) trust to sell 3,000 shares under Rule 144

Rhea-AI Filing Summary

Revolution Medicines, Inc. (symbol RVMD) received a Rule 144 notice that The Rebecca Goldsmith Revocable Trust intends to sell up to 3,000 shares of its common stock through Morgan Stanley Smith Barney LLC. The shares are described as Founders Shares acquired from the issuer on 11/25/2014.

The proposed sale relates to common stock listed on NASDAQ, with an indicated aggregate market value of approximately $635,205.00. The filing also notes that 214,336,418 shares of common stock were outstanding as of 08/21/2026. In the past three months, Mark A. Goldsmith sold 10,020 common shares on 06/16/2026 for about $1,564,310.38, and he signed the notice as trustee for the trust.

Key Figures

Shares to be sold under Rule 144: 3,000 shares Aggregate market value of planned sale: $635,205.00 Shares outstanding: 214,336,418 shares +3 more

6 metrics

Shares to be sold under Rule 144 3,000 shares Planned sale by The Rebecca Goldsmith Revocable Trust

Aggregate market value of planned sale $635,205.00 Indicated value of 3,000 common shares

Shares outstanding 214,336,418 shares Common stock outstanding as of 08/21/2026

Prior 3-month sale shares 10,020 shares Shares sold by Mark A. Goldsmith on 06/16/2026

Proceeds from prior 3-month sale $1,564,310.38 Total consideration for 10,020 shares sold on 06/16/2026

Acquisition date of Founders Shares 11/25/2014 Acquisition date of shares to be sold

Key Terms

Rule 144, Founders Shares, revocable trust, Securities To Be Sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founders Shares financial

"Common | 11/25/2014 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

revocable trust financial

"Name of Person for Whose Account the Securities are To Be Sold | THE REBECCA GOLDSMITH REVOCABLE TRUST"

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

Securities To Be Sold financial

"144: Securities To Be Sold Common | 11/25/2014"

FAQ

What does the Form 144 filing for RVMD disclose about upcoming share sales?

It discloses that The Rebecca Goldsmith Revocable Trust intends to sell up to 3,000 shares of Revolution Medicines, Inc. common stock under Rule 144. The proposed sale will be executed through Morgan Stanley Smith Barney LLC as the broker.

Who is selling RVMD shares in this Form 144 and in what capacity?

The seller is The Rebecca Goldsmith Revocable Trust, with Mark A. Goldsmith signing the notice as Trustee. The filing states the shares are to be sold for the account of this trust.

How many RVMD shares are planned to be sold and what is their market value?

The notice covers a planned sale of up to 3,000 shares of Revolution Medicines common stock, with an indicated aggregate market value of approximately $635,205.00 based on the pricing information included in the filing.

What prior RVMD share sales are reported in the last three months?

The filing reports that Mark A. Goldsmith sold 10,020 shares of RVMD common stock on 06/16/2026 for total proceeds of about $1,564,310.38 during the three months preceding this notice.

How many Revolution Medicines (RVMD) shares were outstanding at the time of the notice?

The Form 144 indicates that 214,336,418 shares of Revolution Medicines common stock were outstanding as of 08/21/2026, providing a reference point for the size of the reported share sale relative to total shares.

On which market are the RVMD shares in this Form 144 traded and who is the broker?

The common stock referenced in the Form 144 is listed on NASDAQ. The executing broker named for the proposed sale is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 04:38 PM Accepted by SEC EDGAR 08/21/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001246842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REVOLUTION MEDICINES INC
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	THE REBECCA GOLDSMITH REVOCABLE TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	635205.00	214336418	08/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/25/2014	Founders Shares	Issuer			3000	11/25/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK A GOLDSMITH 700 Saginaw Drive Redwood City CA 94063	Common	06/16/2026	10020	1564310.38

144: Remarks and Signature

Remarks
Date of Notice	08/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark A Goldsmith, Trustee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)